ERBB2 and breast carcinoma: This study has certain limitations: (1) Given database constraints, we were unable to obtain key clinical and pathological information regarding breast cancer, such as tumor staging (e.g., TNM staging), molecular subtypes (ER/PR/HER2 status), and the presence of distant metastasis.